Skip to main content

Diagnostic options Β· UAE

Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 166–180 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3477
CNGB3 Gene Achromatopsia Type 3 Genetic Test

This test identifies pathogenic variants within the CNGB3 gene, confirming a diagnosis of achromatopsia type 3.

Whole Blood (EDTA), Extracted DNA, Dried Blood Spot (FTA card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CNGB3 gene sequence", "Copy Number Variations (CNVs) in CNGB3 gene"]
Parameters
[]
Preparation
[]
Indications
["Clinical signs of achromatopsia", "Documented family history of CNGB3-related disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: H53.51
Clinical summary
This test identifies pathogenic variants within the CNGB3 gene, confirming a diagnosis of achromatopsia type 3.
TEST-523
CNS Tumor Targeted Gene Panel (Cancer Genomics) Test

This test evaluates key genes in CNS tumor tissue using NGS, FISH, and IHC to identify actionable genomic alterations for diagnosis and treatment guidance.

Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block (Archival Tissue Specimen) 10 Working Days (Sample arrival by Tuesday 9:00 AM) 3,500.00 AED
View
View test specifications and preparation
What it measures
["Gene mutations", "Gene fusions", "Copy number variations", "Protein expression (via IHC)"]
Parameters
[]
Preparation
["No patient preparation required", "Physician provides formalin-fixed paraffin-embedded tissue block", "Completed NGS Test Requisition Form (Form 40) required"]
Indications
["Diagnosis of CNS tumors", "Prognosis assessment", "Targeted therapy selection", "Identification of actionable genetic alterations"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93438-0 ICD-10: C71.9
Clinical summary
This test evaluates key genes in CNS tumor tissue using NGS, FISH, and IHC to identify actionable genomic alterations for diagnosis and treatment guidance.
TEST-3632
COL15A1 Gene Early-Onset Glaucoma, Phenotype Modifier, COL15A1‑Related Genetic Test

This test evaluates the COL15A1 gene for pathogenic variants associated with early-onset glaucoma.

Peripheral whole blood, dried blood spots (FTA card), or previously extracted DNA 3–4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COL15A1 gene", "Single nucleotide variants", "Indels", "Copy number changes"]
Parameters
[]
Preparation
["No fasting required", "No special preparation required"]
Indications
["Individuals with a family history of early-onset glaucoma", "Individuals suspected of having early-onset glaucoma", "Risk assessment for relatives of affected individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 103105-3 ICD-10: H40.1390, H40.0, Z15.8
Clinical summary
This test evaluates the COL15A1 gene for pathogenic variants associated with early-onset glaucoma.
TEST-3137
COL2A1 Gene Achondrogenesis Type 2 Genetic Test

This genetic test identifies pathogenic variants in the COL2A1 gene associated with Achondrogenesis Type 2.

Whole blood (EDTA), extracted DNA, or FTA card 3–4 weeks (rush: 10–12 business days) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in COL2A1 gene", "Exonic and splice-site regions", "Copy Number Variations (CNVs)", "Maternal cell contamination"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Prenatal diagnosis of suspected Achondrogenesis Type 2", "Confirmation of clinical diagnosis", "Carrier screening", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93400-5 ICD-10: Q77.0
Clinical summary
This genetic test identifies pathogenic variants in the COL2A1 gene associated with Achondrogenesis Type 2.
TEST-1695
Colorectal Cancer Panel (NRAS, KRAS, BRAF) Test

This test identifies mutations in the NRAS, KRAS, and BRAF genes within colorectal tumor tissue.

Formalin-fixed paraffin-embedded (FFPE) tissue block or fresh tumor biopsy 7–8 working days 3,600.00 AED
View
View test specifications and preparation
What it measures
["NRAS gene mutations", "KRAS gene mutations", "BRAF gene mutations"]
Parameters
[]
Preparation
["No fasting or special preparation is needed"]
Indications
["Patients with colorectal adenocarcinoma", "Patients being considered for anti-EGFR therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101596-7 ICD-10: C18.9, C19, C20
Clinical summary
This test identifies mutations in the NRAS, KRAS, and BRAF genes within colorectal tumor tissue.
TEST-1693
Complete Inherited Disease Panel Test

This test screens for pathogenic variants in thousands of genes associated with inherited disorders using Next-Generation Sequencing (NGS). It identifies mutations linked to variou...

Peripheral blood, amniotic fluid, or chorionic villi 4–6 weeks 4,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in genes associated with inherited disorders", "Coverage of over 2,000 genes"]
Parameters
[]
Preparation
["A physician’s prescription is usually required.", "Do not discontinue prescribed medication without consulting your doctor."]
Indications
["Screening for inherited diseases", "Diagnosis of suspected genetic disorders", "Pre-conception carrier screening", "Prenatal diagnosis (via amniotic fluid or chorionic villi)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-0 ICD-10: Z13.89
Clinical summary
This test screens for pathogenic variants in thousands of genes associated with inherited disorders using Next-Generation Sequencing (NGS). It identifies mutations linked to various hereditary metabolic, hematologic, and neurological diseases.
TEST-5
Comprehensive Alpha and Beta Thalassemia Gene Panel Test

This test evaluates the HBA1, HBA2, and HBB genes for mutations associated with alpha and beta thalassemia.

EDTA blood tube 4 weeks 2,500.00 AED
View
View test specifications and preparation
What it measures
["HBA1 gene variants", "HBA2 gene variants", "HBB gene variants", "Point mutations", "Copy number variants (CNVs)", "Rare variants"]
Parameters
[]
Preparation
["No fasting required."]
Indications
["Carrier screening", "Diagnosis of thalassemia major/intermedia", "Family planning", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96532-1 ICD-10: D56.1
Clinical summary
This test evaluates the HBA1, HBA2, and HBB genes for mutations associated with alpha and beta thalassemia.
TEST-5807
Comprehensive Ear Nose Throat Panel Genetic Test

This genetic test analyzes over 225 genes to identify mutations associated with hereditary hearing loss and ENT disorders.

Peripheral whole blood (EDTA) or FTA card dried blood spot 3–4 weeks 3,000.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic and likely pathogenic variants in 225+ genes", "Genetic mutations associated with hereditary hearing loss", "Genetic mutations associated with congenital ear malformations", "Genetic mutations associated with syndromic/non-syndromic ENT disorders"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of hereditary hearing loss", "Diagnosis of congenital ear malformations", "Diagnosis of syndromic or non-syndromic ENT disorders", "Family planning and recurrence risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-0 ICD-10: H90.5, H90.3, H91.90, Z14.8
Clinical summary
This genetic test analyzes over 225 genes to identify mutations associated with hereditary hearing loss and ENT disorders.
TEST-2783
Comprehensive Hereditary Cancer Panel (190 Genes) Test

This test evaluates 190 genes associated with inherited cancer syndromes using Next Generation Sequencing (NGS). It identifies single nucleotide variants, small insertions/deletion...

Peripheral whole blood (EDTA) 4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
["A completed Oncopro Hereditary Cancer Risk Clinical Information Form (Form 27) must be submitted before sample collection."]
Indications
["Individuals with a personal or family history suggestive of hereditary cancer syndromes.", "Risk assessment for individuals with specific cancer types (e.g., breast, ovarian, colorectal, prostate).", "Guiding personalized cancer screening and prevention strategies."]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88866-5 ICD-10: Z15.09
Clinical summary
This test evaluates 190 genes associated with inherited cancer syndromes using Next Generation Sequencing (NGS). It identifies single nucleotide variants, small insertions/deletions, and copy number variations (CNVs) in the covered regions.
TEST-18
Comprehensive Tumor Genomic Profiling Panel (526 Genes, SNVs, Indels, Fusions, TMB, MSI) Test

This test evaluates the genomic alterations within a tumor, including mutations, fusions, TMB, and MSI.

Archival FFPE Tumor Tissue Block (Solid Tissue Specimen) 4 weeks 12,000.00 AED
View
View test specifications and preparation
What it measures
["Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Gene Fusions", "Tumor Mutational Burden (TMB)", "Microsatellite Instability (MSI)"]
Parameters
[]
Preparation
[]
Indications
["Confirmed cancer diagnosis", "Valid clinical suspicion of cancer", "Advanced or rare cancers", "Failure of standard therapies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 61313-1 ICD-10: C80.1
Clinical summary
This test evaluates the genomic alterations within a tumor, including mutations, fusions, TMB, and MSI.
TEST-477
Comprehensive Tumor Panel 270 Genes + PD‑L1 Test

This diagnostic test evaluates 270 cancer-associated genes and PD-L1 protein expression in solid tumour tissue using NGS and IHC.

Solid tumour tissue – fresh core needle biopsy or archival FFPE block 10–12 working days 6,000.00 AED
View
View test specifications and preparation
What it measures
["Mutations in 270 cancer-associated genes", "Copy number alterations", "Gene fusions", "PD-L1 protein expression"]
Parameters
[]
Preparation
["No fasting required", "No medication changes required"]
Indications
["Patients with advanced or metastatic solid tumours", "Patients with rare cancers", "Patients who have exhausted standard therapy lines", "Individuals with a strong family history of cancer seeking risk stratification"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 91854-6 ICD-10: C80.1
Clinical summary
This diagnostic test evaluates 270 cancer-associated genes and PD-L1 protein expression in solid tumour tissue using NGS and IHC.
TEST-1689
Congenital Myopathy Gene Panel Test

This test identifies genetic mutations associated with various forms of congenital myopathy.

Amniotic Fluid, Chorionic Villi, Peripheral Blood 4–6 weeks (expedited reporting for critical neonates) 4,800.00 AED
View
View test specifications and preparation
What it measures
["Genetic mutations in over 35 congenital myopathy genes", "Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Consult physician regarding medication adjustments"]
Indications
["Suspected congenital myopathy", "Differential diagnosis of muscle weakness", "Family screening for inherited myopathies", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88826-7 ICD-10: G71.2
Clinical summary
This test identifies genetic mutations associated with various forms of congenital myopathy.
TEST-360
Corn GMO Testing Test

This test measures circulating cell-free DNA fragments from genetically modified corn in whole blood.

Whole Blood (Peripheral) 5–7 working days 1,000.00 AED
View
View test specifications and preparation
What it measures
["Circulating cell-free DNA fragments specific to genetically modified corn events (e.g., MON810, NK603)", "Recent dietary exposure to transgenic corn"]
Parameters
[]
Preparation
["No fasting or dietary restrictions are required.", "Avoid consuming any corn-based products (popcorn, corn syrup) for 6 hours before the appointment."]
Indications
["Assessment of recent dietary exposure to transgenic corn", "Evaluation of xenobiotic load in wellness protocols", "Guiding personalized dietary modifications"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 97528-1 ICD-10: Z13.8
Clinical summary
This test measures circulating cell-free DNA fragments from genetically modified corn in whole blood.
TEST-355
Cotton GMO Testing Test

This diagnostic test evaluates cotton products for the presence of specific genetically modified DNA sequences using real-time PCR.

Cotton products (fabrics, raw cotton, processed goods) 1 Week (expedited options available) 1,000.00 AED
View
View test specifications and preparation
What it measures
["Presence of Cry1Ab transgenic sequences", "Presence of EPSPS transgenic sequences"]
Parameters
[]
Preparation
[]
Indications
["Assessment of potential hypersensitivity reactions to GMO cotton", "Verification of non-GMO standards in cotton products", "Regulatory compliance for manufacturers", "Investigation of adverse reactions to cotton products"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 90440-7 ICD-10: Z13.89
Clinical summary
This diagnostic test evaluates cotton products for the presence of specific genetically modified DNA sequences using real-time PCR.
TEST-735
COVID-19 Xpert Panel Test

This diagnostic panel evaluates the presence of SARS-CoV-2 viral RNA, antibodies (IgG/IgM), and inflammatory markers using multiple methodologies.

Nasopharyngeal swab, EDTA whole blood, Serum separator tube Same-day (sample by 11 AM) 650.00 AED
View
View test specifications and preparation
What it measures
["Viral RNA (SARS-CoV-2)", "IgG/IgM antibodies", "Complete Blood Count (CBC)", "Inflammation markers"]
Parameters
[{"name": "Viral RNA", "reference_range": "Detected/Not Detected"}, {"name": "IgG antibodies", "reference_range": "Qualitative/Quantitative (CLIA)"}, {"name": "IgM antibodies", "reference_range": "Qualitative/Quantitative (CLIA)"}, {"name": "Complete Blood Count (CBC)", "reference_range": "Standard reference ranges apply"}, {"name": "Inflammation markers", "reference_range": "Standard reference ranges apply"}]
Preparation
["Complete the COVID-19 Clinical Information Form prior to collection.", "Inform the phlebotomist of any known allergies to latex or antiseptics."]
Indications
["Diagnosis of active COVID-19 infection", "Assessment of immune response to infection or vaccination", "Monitoring disease progression", "Evaluation of inflammatory status related to COVID-19"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94534-5 ICD-10: U07.1, U07.2
Clinical summary
This diagnostic panel evaluates the presence of SARS-CoV-2 viral RNA, antibodies (IgG/IgM), and inflammatory markers using multiple methodologies.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area